Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genoray Co., Ltd. (122310:KRX), powered by AI.
Genoray Co., Ltd. is currently trading at ₩3,570. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genoray Co., Ltd. on Alpha Lenz.
Genoray Co., Ltd.'s P/E ratio is 68.6.
“Genoray Co., Ltd. trades at a P/E of 68.6 (premium valuation) with modest ROE of 0.9%.”
Ask for details →Genoray Co., Ltd. is a prominent player in the medical technology industry, specializing in the development and production of advanced imaging equipment. The company focuses primarily on dental and medical radiology solutions which includes a comprehensive range of X-ray systems. These products are integral in diagnostic procedures across hospitals, dental clinics, and healthcare facilities, contributing significantly to improved patient care and precise diagnosis. Notably, Genoray’s offerings encompass portable and digital X-ray solutions, catering to diverse needs in medical imaging. Founded in 2001 and headquartered in South Korea, Genoray leverages its technological expertise to drive innovation in radiological imaging. The company's products are distinguished by their cutting-edge technology, precision, and user-friendly design, positioning them as reliable tools for medical professionals globally. Genoray's influence extends across various healthcare sectors, substantially impacting the fields of dentistry, orthopedics, and oncology. With a commitment to quality and advanced manufacturing processes, Genoray Co., Ltd. continues to enhance its footprint in the global medical equipment market, supporting health institutions in delivering accurate and efficient medical care.
“Genoray Co., Ltd. trades at a P/E of 68.6 (premium valuation) with modest ROE of 0.9%.”
Ask for details →Genoray Co., Ltd. (ticker: 122310) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 346 employees. Market cap is $52.0B.
The current price is ₩3,570 with a P/E ratio of 68.57x and P/B of 0.61x.
ROE is 0.89% and operating margin is -0.23%. Annual revenue is $108.0B.